Male hormones (called androgens), particularly testosterone and dihydrotestosterone, determine male secondary sex characteristics and stimulate prostate cell growth. When prostate cells, both healthy and cancerous, are deprived of androgens, they no longer proliferate and eventually die.
Hormonal treatment in prostate cancer uses drugs or surgery (orchiectomy) to suppress or block male hormones (androgen), particularly testosterone and...
Read moreAmong the questions that remain unasked of the doctor by most patients, one of the foremost involve the effect of medications and the... Read more »
So many sad stories can make hanging around in the cancer community?downright depressing some days. Even the stories of triumphant... Read more »
By now you have begun to recuperate from your surgery to remove your prostate cancer. The catheter is out and you have been cured of your... Read more »
I was recently contacted by another urologist who asked me a very interesting question - Are you aware of using a radical prostatectomy to... Read more »
Happy New Year. I would like to start the New Year answering one of ProstateCommons SharePosts. An overweight man with diabetes was... Read more »
Source: Agency for Healthcare Research and Quality
Treating Prostate Cancer A Guide for Men With Localized Prostate Cancer Most men have time to learn about all the options for treating their prostate... Read more »
Source: HealthCentral Encyclopedia
Article updated and reviewed by Kevin Knopf, MD, MPH; Director of Clinical Research, Annapolis Oncology Center and Associate Staff, Johns Hopkins... Read more »
Source: ADAM Encyclopedia
Hormone Therapy and ChemotherapyAndrogen Deprivation Therapy (Hormone Therapy)Male hormones (called androgens), particularly testosterone and... Read more »
Source: ADAM Encyclopedia
Sexual problems are defined as difficulty during any stage (desire, arousal, orgasm, and resolution) of the sexual act, which prevents the individual... Read more »
Source: HealthCentral Encyclopedia
Article updated and reviewed by Corey Cutler, MD MPH FRCP(C), Instructor in Medicine, Harvard Medical School, Dana-Farber Cancer Institute on May 11,... Read more »